Literature DB >> 3456708

Recombination and amplification of pyrimidine-rich sequences may be responsible for initiation and progression of the Xq27 fragile site: an hypothesis.

R L Nussbaum, S D Airhart, D H Ledbetter.   

Abstract

HYPOTHESIS: A pyrimidine-rich sequence (PRS) of DNA is present as a normal sequence in the q27 band of the human X chromosome. Under conditions of pyrimidine nucleotide triphosphate deprivation during S phase, deoxyuridine monophosphate is misincorporated and has to be excised during G2 by DNA repair mechanisms. When a simple PRS is present on both homologous X chromosomes during oogenesis, PRS may undergo amplification through non-homologous crossing-over to produce the initial lesion of the fragile (X). Carriers of such initial lesions will be unaffected transmitting females or males. When an X chromosome bearing such an initial lesion is itself paired with a homologous X carrying a simple PRS during oogenesis, a much higher rate of non-homologous crossing-over may occur resulting in progression to an even longer stretch of pyrimidine rich DNA in this region; the increased length of PRS through amplification makes the region too long to be repaired during G2 and allows it to be seen as a fragile site in metaphase chromosome preparations. Furthermore, this amplified lesion may interfere with transcription of one or more genes in this region and produce the phenotype of the Martin-Bell syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456708     DOI: 10.1002/ajmg.1320230162

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  24 in total

Review 1.  Molecular analysis of the fragile X syndrome.

Authors:  M C Hirst; S M Knight; Y Nakahori; A Roche; K E Davies
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Uridine enhances expression of the fragile X chromosome in human lymphocytes.

Authors:  M Kähkönen; R Haataja; J Leisti
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

3.  Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites.

Authors:  F V Rassool; T W McKeithan; M E Neilly; E van Melle; R Espinosa; M M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

4.  The enigma of common fragile sites.

Authors:  I Simonic; G S Gericke
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

Review 5.  Anticipation in hereditary disease: the history of a biomedical concept.

Authors:  Judith E Friedman
Journal:  Hum Genet       Date:  2011-06-12       Impact factor: 4.132

6.  The role of recombination in the evolvement of the fragile X mutation.

Authors:  T Schaap
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

7.  Interpretation of the heterogeneity in the linkage relationships of DNA markers around the fragile X locus.

Authors:  R Winter; M Pembrey
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

8.  Synergistic effect of hydroxyurea and excessive thymidine on the expression of the common fragile sites at 3p14 and 16q23.

Authors:  Z A Yan; X Z Li; X T Zhou
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

9.  Hypothesis regarding the nature of the fragile X mutation. A reply to Winter and Pembrey.

Authors:  W T Brown; S L Sherman; C S Dobkin
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

10.  Molecular heterogeneity of the fragile X syndrome.

Authors:  Y Nakahori; S J Knight; J Holland; C Schwartz; A Roche; J Tarleton; S Wong; T J Flint; U Froster-Iskenius; D Bentley
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.